002370 亚太药业
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--064612,3330
固定资产300,034-11.25%338,079364,755384,499430,506
在建工程1,4574,924.14%29340901
无形资产43,292-20.12%54,19559,20657,22251,572
商誉0--0000
其他非流动资产53,181-2.07%54,30549,55364,977131,952
397,964-10.89%446,608474,193519,030614,933

流动资产
货币资金587,810-20.98%743,851720,475757,617821,113
应收账款103,5498.64%95,31079,51089,05969,964
存货52,774-24.75%70,12989,47595,20560,899
其他流动资产71,85156.63%45,87265,72162,96543,872
815,983-14.57%955,160955,1801,004,845995,849

流动负债
短期借款0-100.00%30,05650,06050,0610
应付票据15,349--02,32030,3700
应付帐款34,671-24.24%45,76549,47759,46153,926
其他流动负债29,437-91.36%340,61659,94782,491160,224
79,458-80.92%416,436161,803222,383214,150
流动资产净值736,52536.72%538,724793,377782,462781,699
资产总额减流动负债1,134,48915.14%985,3321,267,5711,301,4921,396,631

非流动负债
长期借款0--0000
应付债券0--0639,477900,015861,581
其他非流动负债13,3151.25%13,15147,220100,211102,089
13,3151.25%13,151686,6961,000,226963,670

总权益
    实收股本745,6682.34%728,586609,171536,687536,618
    储备项目375,50754.15%243,595(28,297)(235,420)(103,657)
股东权益1,121,17415.33%972,181580,874301,267432,962
非控股权益0--0000